Seven checkpoint-related genes (BTLA,CD80, CD86, CTLA4, IDO1, PDCD1LG2, and TIGIT) had decreased expression in the KRAS-mutated group, providing potential opportunities for immunotherapy in colon cancer. The gene discussed is PDCD1LG2; the disease is colonic neoplasm.